Stockreport

Barclays Raises Hims & Hers (HIMS) Target to $29 After Novo Deal Clears Legal Overhang — Canaccord Cuts Progyny (PGNY) on Cautious 2026 Outlook [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF Quick Read Hims & Hers Health (HIMS) reached $2.347 billion in full-year revenue, up 59% year-over-year, with a subscriber base crossing 2.5 million and monthly reven [Read more]